News & Updates
Filter by Specialty:
PSOARING trials boost potential of tapinarof for plaque psoriasis
The nonsteroidal topical aryl hydrocarbon receptor (AHR)-modulating agent tapinarof 1% trumped a vehicle control cream in reducing the severity and manifestations of plaque psoriasis, according to the phase III PSOARING 1 and 2 trials.
PSOARING trials boost potential of tapinarof for plaque psoriasis
21 Jan 2022Osteoporosis a cause for concern in Singapore’s rapidly ageing population
Osteoporosis is a common condition in adults aged 50 years and above, particularly among those with distal radius fractures, and pressing problem in Singapore considering its rapidly ageing population, according to a recent study.
Osteoporosis a cause for concern in Singapore’s rapidly ageing population
21 Jan 2022Aspirin does not cut death risk in hospitalized COVID-19 patients
Adding aspirin to usual care did not lead to a reduced mortality rate in patients hospitalized with COVID-19, according to a study by the RECOVERY* Collaborative Group.
Aspirin does not cut death risk in hospitalized COVID-19 patients
20 Jan 2022Tranexamic acid ups blood control after CABG, but aggravates perioperative myocardial infarction
While tranexamic acid improves blood control after coronary artery bypass graft (CABG) surgery, it increases the risk of perioperative myocardial infarction, a recent study has found.
Tranexamic acid ups blood control after CABG, but aggravates perioperative myocardial infarction
20 Jan 2022High-salt diet hastens vascular ageing in kids
Increased levels of dietary sodium (Na) intake and load (Na-L) appear to cause arterial stiffness, a preclinical measure of cardiovascular disease (CVD), in children and young adults, according to a study.